MISSING AMYLOIDOSIS? A MULTIDISCIPLINARY UPDATE ON THE IMPROVED DIAGNOSTICS, TREATMENTS AND SURVIVAL OF AMYLOIDOSIS PATIENTS IN 2015 AND BEYOND

Publisher： John Wiley & Sons Inc

E-ISSN： 1445-5994|45|S3|9-9

ISSN： 1444-0903

Source： INTERNAL MEDICINE JOURNAL, Vol.45, Iss.S3, 2015-05, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Testicular Amyloidosis

By  

Urologia Internationalis, Vol. 69, Iss. 2, 2002-08 ,pp. : 162-163

Karger

Access to resources Recommend Favorite

THAOS – The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis

By Coelho Teresa   Maurer Mathew S.   Suhr Ole B.  

Current Medical Research and Opinion, Vol. 29, Iss. 1, 2013-01 ,pp. : 63-76

Informa Healthcare

Access to resources Recommend Favorite

Changes in cardiac biomarkers with bortezomib treatment in patients with advanced cardiac amyloidosis

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 11, 2015-11 ,pp. : E212-E213

John Wiley & Sons Inc

Access to resources Recommend Favorite

Detection of monoclonal plasma cells in the peripheral blood of patients with primary amyloidosis

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 2, 1998-02 ,pp. : 326-327

John Wiley & Sons Inc

Access to resources Recommend Favorite

Characteristics and Long-Term Outcome of Patients with Systemic Immunoglobulin Light-Chain Amyloidosis

By  

Acta Haematologica, Vol. 133, Iss. 4, 2014-12 ,pp. : 336-346

Karger

Access to resources Recommend Favorite